Any current/future capex/capital investment/strategic investment?

The transcript does not explicitly mention current or future capital expenditure (capex) plans. The company discusses inorganic opportunities and mentions deploying relevant opportunities inorganically, suggesting potential strategic investments. Honasa emphasizes building a robust organization and acquiring the right talent to pursue new opportunities, indicating ongoing strategic investments in human capital. Expansion plans include extending distribution of acquired brand Reginald Men, category expansion, and unlocking new geographies, which imply capital allocation toward growth. Investmen

Future growth expectations in sales/revenue/volumes?

Honasa Consumer Limited targets a high-teens CAGR growth in revenue over the next 5 years. They plan to achieve at least 500 basis points improvement in EBITDA margins over the same period. Younger brands are expected to continue driving strong growth, with some growing at around 40%. Core brands like Mamaearth and Derma Co. are anticipated to sustain double-digit growth with margin improvements. Expansion plans include increasing distribution outlets for brands such as Mamaearth from 200,000 to 500,000 in 3-5 years. Increasing contribution from focus categories, which grew 35% year-on-year an

Future growth expectations in earnings/operating earnings/profits/EPS?

Honasa Consumer Limited plans to grow at a high-teens CAGR over the next 5 years. The company aims to improve EBITDA margins by about 500 basis points over the same period. Growth will be driven by volume growth, premiumization strategy, and focus on key brands and categories. Younger brands, including recent acquisitions like Reginald Men, are expected to sustain strong double-digit growth. Mamaearth is expected to grow at a double-digit CAGR over the next 5 years, with significant opportunities for distribution expansion and category penetration. The focus categories receive over 90% of inve

Honasa ConsumerQ4 FY26Personal Products

Honasa Consumer Q4 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹484.05P/E: 55.2Market Cap: ₹15.8K CrSector: Personal Products

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Honasa Consumer Limited targets a high-teens CAGR growth in revenue over the next 5 years.
They plan to achieve at least 500 basis points improvement in EBITDA margins over the same period.
Younger brands are expected to continue driving strong growth, with some growing at around 40%.
Core brands like Mamaearth and Derma Co. are anticipated to sustain double-digit growth with margin improvements.
Expansion plans include increasing distribution outlets for brands such as Mamaearth from 200,000 to 500,000 in 3-5 years.
Increasing contribution from focus categories, which grew 35% year-on-year and now receive over 90% of investments.
Growth drivers include product innovation, category expansion (e.g., Reginald moving beyond sunscreens), and geographic expansion into states like Maharashtra.
The company emphasizes volume-driven growth complemented by calibrated price increases to manage inflation.

Margin guidance

Category 1

Honasa Consumer Limited plans to grow at a high-teens CAGR over the next 5 years.
The company aims to improve EBITDA margins by about 500 basis points over the same period.
Growth will be driven by volume growth, premiumization strategy, and focus on key brands and categories.
Younger brands, including recent acquisitions like Reginald Men, are expected to sustain strong double-digit growth.
Mamaearth is expected to grow at a double-digit CAGR over the next 5 years, with significant opportunities for distribution expansion and category penetration.
The focus categories receive over 90% of investment and are expected to continue as primary growth drivers.
The company aims to deliver about 100 basis points of EBITDA margin improvement annually, with some years exceeding this target depending on strategy.
Overall, management is confident of consistent growth in earnings, operating profits, and EPS aligned with these strategic plans.

See what Honasa Consumer management said on margin guidance — free account, 30 seconds.

Fundraise plans

The document does not explicitly mention any current or planned future fundraising through debt or equity for Honasa Consumer Limited. However, some relevant points include: - The company generated excess cash and declared a dividend of INR 3 per equity share (about 50% of PAT), signaling strong ongoing cash generation. - Management mentioned deploying cash for "relevant opportunities in inorganic" growth. - There is no direct reference to raising fresh debt or equity in the discussed period. - The focus appears on organic growth and strategic acquisitions rather than fundraising. In summary, no explicit plans or ongoing activities related to new debt or equity fundraising have been stated in the provided information.

Order book

The provided transcript from Honasa Consumer Limited's Q4 and FY26 earnings call does not mention any information regarding the current or expected order book or pending orders. The discussion primarily focuses on: - Financial performance including revenue, EBITDA, and PAT growth. - Brand growth strategies, especially for Mamaearth, Derma Co., and Reginald Men. - Market expansion and distribution plans. - Margin improvement guidance and focus on premiumization. - Channel growth including GT (general trade) performance. - No mention or disclosure of an order book or pending orders status. Therefore, no specific data about order book or pending orders is available in this transcript.

See what Honasa Consumer management said on order book — free account, 30 seconds.

Capex plans

Yes

The transcript does not explicitly mention current or future capital expenditure (capex) plans.
The company discusses inorganic opportunities and mentions deploying relevant opportunities inorganically, suggesting potential strategic investments.
Honasa emphasizes building a robust organization and acquiring the right talent to pursue new opportunities, indicating ongoing strategic investments in human capital.
Expansion plans include extending distribution of acquired brand Reginald Men, category expansion, and unlocking new geographies, which imply capital allocation toward growth.
Investments focus heavily on brand building, innovation, expanding distribution channels, and stabilizing offline systems.
There is no direct mention of large-scale plant, machinery, or infrastructure capex in the provided pages.

Track Honasa Consumer — get its next earnings analysis in your feed

How does Honasa Consumer rank vs peers in Personal Products?

Pro feature

ThisHonasa Consumer

Rev 3Mar 1

See where Honasa Consumer sits in Personal ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Honasa Consumer rank in Personal Products?

Compare Honasa Consumer against every Personal Products company (Q4 FY26) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

What Honasa Consumer's management said in earlier quarters

Earlier calls (7)

Others in Personal Products this season

Emami (Q2 FY27)
Q2FY27 Revenue from Operations:** ₹1,088 crore, up 36% year-on-year . Key investor presentation takeaways from Emami Ltd's Q2 FY27 investor presentation — and h
Dabur India (Q2 FY27)
Consolidated Revenue: INR 3,563.1 crores in Q2 FY27, up 11.6% YoY (Page 27) . Key investor presentation takeaways from Dabur India Ltd's Q2 FY27 investor presen
JHS Svendgaard Laboratories (Q2 FY27)
2,077.1 lakhs in the same quarter of 2025, which reflects an approximate year-on-year growth of 10.8%. Key results statement takeaways from JHS Svendgaard Labor
Aakaar Medical (Q2 FY27)
The company has seen strong revenue growth, with H1 FY27 revenue at INR 43.72 crores, up 72.64% YoY. Key concall takeaways from Aakaar Medical Technologies…

Compare:vs Godrej Consumer vs Dabur India vs Colgate-Palmoliv

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →